News | October 24, 2025
Laurus Labs posts Q2 FY26 consolidated PAT higher at Rs. 195 Cr
Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025
Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility
Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025
Vimta Labs has reported total income of Rs. 99.31 crores during the period ended June 30, 2025
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Subscribe To Our Newsletter & Stay Updated
